Matches in Nanopublications for { ?s ?p "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP215749.RA_IzuYA5Y0cQ_HpywLxK-JgPHQUhdv5Kzu7LUbmoxDfg130_assertion description "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215749.RA_IzuYA5Y0cQ_HpywLxK-JgPHQUhdv5Kzu7LUbmoxDfg130_provenance.
- NP406870.RAa0PWGQxrcdMHgMuGF_O6z7HbajLMBR5QHp2yM6A05as130_assertion description "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406870.RAa0PWGQxrcdMHgMuGF_O6z7HbajLMBR5QHp2yM6A05as130_provenance.
- NP652168.RAUNik3BHqG_UYVn9whCf2QM02JBddLZ-b3U9De97iHjE130_assertion description "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652168.RAUNik3BHqG_UYVn9whCf2QM02JBddLZ-b3U9De97iHjE130_provenance.
- NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_assertion description "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652167.RAD5dKWz2ePVIt_4dUH7rkPNxVwxT4OAC9yAXxaYnPRVY130_provenance.
- NP629280.RAPNpE2w7olchEtkfov4jzY9LwvgYkns8100TPsN3cIUE130_assertion description "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629280.RAPNpE2w7olchEtkfov4jzY9LwvgYkns8100TPsN3cIUE130_provenance.
- NP629253.RA578_3RflnDBdf8OFhaBJcgVkQQ9a6ZrA5g9hH5-uY1k130_assertion description "[Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629253.RA578_3RflnDBdf8OFhaBJcgVkQQ9a6ZrA5g9hH5-uY1k130_provenance.